Release Date: 20/08/09 09:38 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 14.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%